Enanta Pharmaceuticals reported $43.99M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acorda Therapeutics ACOR:US USD 20.7M 2.43M
Amgen AMGN:US USD 9.5B 4.3B
Anika Therapeutics ANIK:US USD 87.78M 3.62M
Arrowhead Research ARWR:US USD 108M 31.43M
AstraZeneca AZN:LN USD 4.46B 359M
Biocryst Pharmaceuticals BCRX:US USD 461.19M 43.71M
Biogen BIIB:US USD 3.68B 1.03B
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Clovis Oncology CLVS:US USD 58.32M 36.26M
Enanta Pharmaceuticals ENTA:US USD 43.99M 15.63M
Gilead Sciences GILD:US USD 6.94B 2.2B
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Halozyme Therapeutics HALO:US USD 147.16M 56.23M
Heron Therapeutics HRTX:US USD 50.44M 1.83M
Insmed INSM:US USD 414.63M 1.44M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
IONIS PHARMACEUT IONS:US USD 314.99M 206.92M
Karyopharm Therapeutics KPTI:US USD 71.35M 10.9M
Ligand Pharmaceuticals LGND:US USD 121.41M 116.13M
Marinus Pharmaceuticals MRNS:US USD 168.25M 75.92M
Neurocrine Biosciences NBIX:US USD 212.2M 48.9M
Novartis NOVN:VX USD 8.73B 5.1B
Novavax NVAX:US USD 1.28B 95.01M
Ptc Therapeutics PTCT:US USD 104.42M 53.73M
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
Vital Therapies VTL:US USD 72.77M 15.31M
YTE INCY:US USD 2.69B 255.24M